Tech Company Financing Transactions
NeuroSigma Funding Round
On 9/22/2020, NeuroSigma received financing from Checkmate Capital.
Transaction Overview
Company Name
Announced On
9/22/2020
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Checkmate Capital (Thomas Paschall)
Proceeds Purpose
The financing supports NeuroSigma's transition from a clinical-stage to a commercial-stage company.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
10960 Wilshire Blvd. 1910
Los Angeles, CA 90024
USA
Los Angeles, CA 90024
USA
Phone
Website
Email Address
Not Recorded
Overview
NeuroSigma is a California-based life sciences company established to develop bioelectronic technologies with the potential to transform medical practice and patients' lives. NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property, licensed on an exclusive basis from the University of California, Los Angeles (UCLA), covering a wide-spectrum of disorders, including ADHD.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leon Ekchian
Chief Financial Officer
Sam Wild
Chief Medical Officer
Ian Cook
Vice President
Colin Kealey
VP - Engineering
Vikas Gupta
VP - Finance
Philip Oseas
VP - Finance
Charles Winckler
Browse more venture capital transactions:
Prev: 9/22/2020: Canexia Health venture capital transaction
Next: 9/22/2020: Rhombus Energy Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs